Cargando…
The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
Malignant mesothelioma (MM), especially its more frequent form, malignant pleural mesothelioma (MPM), is a devastating thoracic cancer with limited therapeutic options. Recently, clinical trials that used immunotherapy strategies have yielded promising results, but the benefits are restricted to a l...
Autores principales: | Blanquart, Christophe, Jaurand, Marie-Claude, Jean, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109283/ https://www.ncbi.nlm.nih.gov/pubmed/32269966 http://dx.doi.org/10.3389/fonc.2020.00388 |
Ejemplares similares
-
Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020) -
Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023) -
Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis
por: Jean, Didier, et al.
Publicado: (2018) -
Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
por: Johnson, Ben William, et al.
Publicado: (2021) -
Use of preclinical models for malignant pleural mesothelioma
por: Shamseddin, Marie, et al.
Publicado: (2021)